COMMUNIQUÉS West-GlobeNewswire

EB DEVELOPMENT : COMMUNIQUÉ DE PRESSE DU 30 SEPTEMBRE 2024 RELATIF AU DEPÔT D’UNE OFFRE PUBLIQUE D’ACHAT VISANT LES ACTIONS DE LA SOCIÉTÉ EUROBIO SCIENTIFIC
30/09/2024
COMMUNIQUÉ DE PRESSE DU 30 SEPTEMBRE 2024 RELATIF AU DEPÔT D’UNE OFFRE PUBLIQUE D’ACHAT VISANT LES ACTIONS DE LA SOCIÉTÉ Eurobio Scientific INITIÉE PAR EB DEVELOPMENT AGISSANT DE CONCERT AVEC IK X LUXCO 3 S.A R.L, [...]
Total number of shares and voting rights in Zealand Pharma A/S on September 30, 2024
30/09/2024
Company announcement – No. 46 / 2024 Total number of shares and voting rights in Zealand Pharma A/S on September 30, 2024 Copenhagen, Denmark, September 30, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. [...]
Penn Medicine, Rockefeller Neuroscience Institute and Precision Neuroscience Unveil Breakthrough Neural Implant Data at the 2024 Congress of Neurological Surgeons Annual Meeting
30/09/2024
First-of-its-kind in-human studies reveal unprecedented detail in brain signal mapping, advancing brain-computer interface technology NEW YORK, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Today, researchers from the Perelman [...]
Instinct Report: Morale is Trending Up in 2024, but Employee Turnover Remains High in ER & Specialty Hospitals
30/09/2024
PHILADELPHIA, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Instinct Science, a leading technology provider for veterinary hospitals, today announced its second annual State of Emergency and Specialty Veterinary Care Report. Based [...]
Parexel Earns Prestigious Society for Clinical Research Sites Eagle Award for Second Consecutive Year
30/09/2024
Global investigative sites recognize Parexel’s commitment to strong site relationships and patients DURHAM, N.C., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Parexel , one of the world’s largest clinical research organizations ( [...]
UPDATE -- ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
30/09/2024
ResMed makes it easier for people to manage their sleep health and stay on (continuous positive airway pressure) CPAP treatment by integrating its leading myAir ™ consumer app with Apple and Android smartwatches. [...]
AssureCare Welcomes Stacy Mountain as Vice President of Sales
30/09/2024
CINCINNATI, Sept. 30, 2024 (GLOBE NEWSWIRE) -- AssureCare , a leading provider of Population Health Management solutions, is proud to welcome Stacy Mountain as the new Vice President of Sales. Stacy will lead the [...]
FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa
30/09/2024
Chief Scientific Officer, Hamid Khoja, Ph.D., to provide update on Psoriasis and Wound Care programs HOUSTON, Sept. 30, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage [...]
Drs. Javier, Perez, and Roth Collaborate with Castle Connolly Private Health Partners to Create Joint Concierge Program, Precision Concierge Physicians
30/09/2024
Precision Concierge Physicians — for patients who desire a personalized approach to their healthcare NAPLES, Fla., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Castle Connolly Private Health Partners, LLC (CCPHP), a leader in [...]
SciSparc Secures FDA Green Light to US Launch of its Pivotal Phase IIb Clinical Trial for Breakthrough Tourette Syndrome Treatment
30/09/2024
FDA confirm s that SciSparc’s study may proceed only a month after application submission TEL AVIV, Israel, Sept. 30, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical [...]
UPDATE -- ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
30/09/2024
The new AirTouch™ N30i tube-up nasal mask for CPAP combines softness, breathability, and a high-performance, durable seal to provide exceptional comfort SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, [...]
Cytokinetics Presents Additional Data From SEQUOIA-HCM at the HFSA Annual Scientific Meeting
30/09/2024
Responder Analyses Show Treatment with Aficamten Demonstrated Improvements on Multiple Assessments of Clinical Significance to Cardiologists Results Simultaneously Published in the Journal of the American College of [...]
Sonnet BioTherapeutics Announces Launch of CEO Corner Platform
30/09/2024
CEO Corner segments to include additional discussion related to press releases, events, corporate updates and pipeline progress Provides interested parties the ability to ask questions and submit topics for future [...]
MediciNova to Support NIH-Funded Expanded Access Clinical Trial to Evaluate MN166 (ibudilast) in Amyotrophic Lateral Sclerosis (ALS)
30/09/2024
Academic group to receive a total of $22 million for the trial LA JOLLA, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the [...]
AIM ImmunoTech Announces Pricing of $1.26 Million Registered Direct Offering
30/09/2024
OCALA, Fla., Sept. 30, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it has entered into a securities purchase agreement with a single institutional [...]
Clene Announces $7.3 Million Registered Direct Offering and Concurrent Private Placements Priced at Market Under Nasdaq Rules
30/09/2024
SALT LAKE CITY, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly-owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company [...]
Wave Life Sciences to Present at Chardan 8th Annual Genetic Medicines Conference
30/09/2024
CAMBRIDGE, Mass., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, [...]
Digicann Ventures Signs Definitive Agreement for Proposed RTO Transaction with 3Win Corp.
28/09/2024
/ Not for distribution to U.S. news wire services or for dissemination in the United States / VANCOUVER, British Columbia, Sept. 28, 2024 (GLOBE NEWSWIRE) -- Digicann Ventures Ltd. (“Digicann” or the “Company”) (CSE: [...]
Enliven Therapeutics Announces Positive Data Update from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia
28/09/2024
Updated Phase 1 data presented at ESH-iCMLf 26 th Annual John Goldman Conference Reported cumulative MMR rate of 44% (8/18) by 24 weeks, with stable or deepening responses between weeks 12 and 24, which continues to [...]

Pages